COMP <GO>
PGNY vs UNH // EV/EBITDA & P/E VALUATION
Progyny Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: PGNY 7
— UNH 5
▲ EV/EBITDA & P/E VALUATION LEADER: UNH
LAST: $28.40 (+1.90%) • MKT CAP: $2.18B
valuation
20.5x
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGNY VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PGNY | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.60% | 88.57% | -64.97 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.70% | 11.47% | +5.23 | PGNY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 20.5x | 16.4x | +4.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 8.80% | 6.48% | +2.32 | PGNY | /fcf-yield <GO> |
| Operating Margin | 6.60% | 4.82% | +1.78 | PGNY | /operating-margins <GO> |
| Net Profit Margin | 4.50% | 3.14% | +1.36 | PGNY | /net-margins <GO> |
| Revenue Growth (YoY) | 10.40% | 6.46% | +3.94 | PGNY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.84 | 3.12 | +5.72 | PGNY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.0 | 59.2 | +2.82 | PGNY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.6x | 17.1x | +17.51 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.18B | $368.83B | -$366.65B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PGNY REV | UNH REV | PGNY GROSS % | UNH GROSS % | PGNY FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.29B | $447.57B | 23.6% | 88.7% | $191.8M | $16.07B |
| FY 2024 | $1.17B | $400.28B | 21.7% | 88.3% | $173.7M | $20.70B |
| FY 2023 | $1.09B | $371.62B | — | 89.6% | $188.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGNY // BETA —
UNH // BETA 0.33